JP2000510472A - 抗炎症および免疫抑制活性を有する化合物 - Google Patents
抗炎症および免疫抑制活性を有する化合物Info
- Publication number
- JP2000510472A JP2000510472A JP09540505A JP54050597A JP2000510472A JP 2000510472 A JP2000510472 A JP 2000510472A JP 09540505 A JP09540505 A JP 09540505A JP 54050597 A JP54050597 A JP 54050597A JP 2000510472 A JP2000510472 A JP 2000510472A
- Authority
- JP
- Japan
- Prior art keywords
- mmol
- acid
- naphth
- alkyl
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/10—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
- C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/18—Fluorenes; Hydrogenated fluorenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
- C07C2603/74—Adamantanes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Transplantation (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.式: 〔式中、R’は水素または(C1-4)アルキル; AはN、SまたはOからなる群から選ばれる1つ以上のヘテロ原子を含有する ことができ、かつ必要に応じてヒドロキシ、アルカノイルオキシ、第一,第二も しくは第三アミノ、アミノ(C1-4)アルキル、モノもしくはジ(C1-4)アルキ ル−アミノ(C1-4)アルキル、ハロゲン、(C1-4)アルキル、トリ(C1-4) アルキルアンモニウム(C1-4)アルキルで置換されてよい、アダマンチルまた は必要に応じて一部もしくは全部不飽和のモノ,ジもしくはトリ環式残基; を有してよい炭素数1〜5の鎖; Rは水素またはフェニル; Xは酸素原子またはNR’基(ここで、R’は前記と同意義)、あるいは非存 在; rおよびmは独立して0、1または2; Bはフェニレンまたはシクロヘキシレン環: Yはヒドロキシまたは必要に応じて酸素原子を介したアミノ(C1-4)アルキ ル鎖 であって、但し、上記Aの場合に定義するトリ環式基は、XがOでなく同時にY がヒドロキシでないときのみ、トリ(C1-4)アルキルアンモニウム(C1-4)ア ルキル基で置換されていないことを条件にフルオレニルである〕 で示される化合物。 2.R’が水素;Aが必要に応じて請求の範囲1に記載の如く置換されたフェ ニル、1−もしくは2−ナフチル、シクロヘキシル、1−もしくは2−1,2, 3,4−テトラヒドロナフチル、アダマンチル、キノリニル、イソキノリニル、 1−もしくは2−インデニル、テトラヒドロキノリニル、テトラヒドロイソキノ 囲1の記載と同意義である請求の範囲1に記載の化合物。 3.R’が水素;Aが必要に応じて置換されたフェニルまたは1−もしくは2 −ナフチル;AがフェニルのときRがフェニル、またはAが1−もしくは2−ナ フチルのときRが水素;R,B,mおよびrが請求の範囲1の記載と同意義;Y がOHおよびC1-C5アルキレン鎖が請求の範囲2の記載と同意義である請求の 範囲1に記載の化合物。 4.抗炎症剤として好適な薬剤の製造に用いる請求の範囲1に記載の化合物の 用途。 5.免疫抑制剤として好適な薬剤の製造に用いる請求の範囲1に記載の化合物 の用途。 6.活性成分として請求の範囲1に記載の化合物の少なくとも1種と、医薬的 に許容しうる賦形剤を共に含有する医薬組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT96A000968 | 1996-05-14 | ||
IT96MI000968A IT1283637B1 (it) | 1996-05-14 | 1996-05-14 | Composti ad attivita' antinfiammatoria ed immunosoppressiva |
PCT/EP1997/002407 WO1997043251A1 (en) | 1996-05-14 | 1997-05-12 | Compounds with anti-inflammatory and immunosuppressive activities |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2000510472A true JP2000510472A (ja) | 2000-08-15 |
JP4108127B2 JP4108127B2 (ja) | 2008-06-25 |
Family
ID=11374259
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP54050597A Expired - Lifetime JP4108127B2 (ja) | 1996-05-14 | 1997-05-12 | 抗炎症および免疫抑制活性を有する化合物 |
Country Status (19)
Country | Link |
---|---|
US (1) | US6034096A (ja) |
EP (1) | EP0901465B1 (ja) |
JP (1) | JP4108127B2 (ja) |
CN (1) | CN1105100C (ja) |
AU (1) | AU713300B2 (ja) |
BR (1) | BR9709234B8 (ja) |
CA (1) | CA2254066C (ja) |
CZ (1) | CZ293233B6 (ja) |
DE (1) | DE69703207T2 (ja) |
DK (1) | DK0901465T3 (ja) |
ES (1) | ES2151267T3 (ja) |
GR (1) | GR3035128T3 (ja) |
HU (2) | HU225650B1 (ja) |
IT (1) | IT1283637B1 (ja) |
PL (1) | PL187527B1 (ja) |
PT (1) | PT901465E (ja) |
RU (1) | RU2177473C2 (ja) |
SK (1) | SK282174B6 (ja) |
WO (1) | WO1997043251A1 (ja) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002536364A (ja) * | 1999-02-04 | 2002-10-29 | エス ケー コーポレイション | テトラヒドロイソキノリンアルカノール誘導体及びそれを含む薬学的組成物 |
JP2004509941A (ja) * | 2000-09-29 | 2004-04-02 | プロリフィクス リミテッド | Hdacインヒビターとしてのアミド結合を含むカルバミン酸化合物 |
JPWO2003070691A1 (ja) * | 2002-02-21 | 2005-06-09 | 財団法人大阪産業振興機構 | N−ヒドロキシカルボキサミド誘導体 |
JP2006515609A (ja) * | 2003-01-10 | 2006-06-01 | イタルファルマコ ソシエタ ペル アチオニ | 抗炎症性作用を有するヒドロキサム酸誘導体 |
JP4769248B2 (ja) * | 2004-07-05 | 2011-09-07 | イタルファルマコ ソシエタ ペル アチオニ | 抗炎症活性を有するα−アミノ酸誘導体 |
JP2012505872A (ja) * | 2008-10-15 | 2012-03-08 | ジェネリクス・(ユーケー)・リミテッド | ボリノスタットの調製方法 |
US8754129B2 (en) | 2008-11-26 | 2014-06-17 | Generics [Uk] Limited | Crystalline vorinostat form VI |
JP2022527146A (ja) * | 2019-03-06 | 2022-05-31 | イタルファルマコ ソシエタ ペル アチオニ | 高純度を有する{6-[(ジエチルアミノ)メチル]ナフタレン-2-イル}メチル[4-(ヒドロキシカルバモイル)フェニル]カルバメートを製造するための方法 |
JP7507777B2 (ja) | 2019-03-06 | 2024-06-28 | イタルファルマコ ソシエタ ペル アチオニ | 高純度を有する{6-[(ジエチルアミノ)メチル]ナフタレン-2-イル}メチル[4-(ヒドロキシカルバモイル)フェニル]カルバメートを製造するための方法 |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2352740A1 (en) | 1998-12-10 | 2000-06-15 | F. Hoffmann-La Roche Ag | Procollagen c-proteinase inhibitors |
WO2000056725A1 (en) * | 1999-03-19 | 2000-09-28 | Du Pont Pharmaceuticals Company | N-adamant-1-yl-n'-[4-chlorobenzothiazol-2-yl] urea useful in the treatment of inflammation and as an anticancer radiosensitizing agent |
DE60143098D1 (de) * | 2000-05-31 | 2010-10-28 | Santen Pharmaceutical Co Ltd | (Pyridinyl)alkyl-Amide oder -Harnstoffe als TNF-alpha Bildung Inhibitoren |
ITMI20011733A1 (it) * | 2001-08-07 | 2003-02-07 | Italfarmaco Spa | Derivati dell'acido idrossamico inibitori degli enzimi istone deacetilasi, quali nuovi farmaci antiinfiammatori inibenti la sintesi di citoc |
PE20030701A1 (es) * | 2001-12-20 | 2003-08-21 | Schering Corp | Compuestos para el tratamiento de trastornos inflamatorios |
ITMI20030063A1 (it) * | 2003-01-17 | 2004-07-18 | Italfarmaco Spa | Cloridrato monoidrato dell'estere (6-dietilamminometil-naftalen-2-il)metilico dell'acido (4-idrossicarbammoil-fenil)carbammico. |
ITMI20030064A1 (it) | 2003-01-17 | 2004-07-18 | Italfarmaco Spa | Uso dei derivati dell'acido idrossamico per la preparazione |
US7291744B2 (en) | 2003-11-13 | 2007-11-06 | Bristol-Myers Squibb Company | N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity |
HUE028490T2 (en) * | 2003-12-02 | 2016-12-28 | Univ Ohio State Res Found | Short-chain fatty acids fixed to the Zn2-chelating motif as a new class of histone deacetylase inhibitors |
EP1768662A2 (en) | 2004-06-24 | 2007-04-04 | Novartis Vaccines and Diagnostics, Inc. | Small molecule immunopotentiators and assays for their detection |
WO2007017728A2 (en) * | 2005-08-05 | 2007-02-15 | Orchid Research Laboratories Limited | Novel heterocyclic compounds |
IT1392908B1 (it) | 2008-09-29 | 2012-04-02 | Italfarmaco Spa | Uso degli inibitori delle istone-deacetilasi per la cura di sindromi mieloproliferative philadelphia-negative |
KR101168801B1 (ko) | 2009-03-27 | 2012-07-25 | 주식회사종근당 | 신규한 하이드록사메이트 유도체, 이의 제조방법, 및 이를 함유하는 약제학적 조성물 |
IT1396915B1 (it) | 2009-10-23 | 2012-12-20 | Italfarmaco Spa | Dietil-[6-(4-idrossicarbamoil-fenil-carbamoilossimetil)-naftalen-2-il-metil]-ammonio cloruro ed altri derivati della n-idrossi-benzammide per l'uso nel trattamento di infezioni da hiv. |
IT1397912B1 (it) | 2010-01-28 | 2013-02-04 | Chemi Spa | Nuovo polimorfo dell'estere 6-dietilamminometil-2-naftilico dell'acido 4-idrossicarbamoil-fenil-carbammico cloridrato. |
US8217079B2 (en) * | 2010-03-26 | 2012-07-10 | Italfarmaco Spa | Method for treating Philadelphia-negative myeloproliferative syndromes |
EP2683371B1 (en) | 2011-03-09 | 2020-10-21 | Cereno Scientific AB | Compounds and methods for improving impaired endogenous fibrinolysis using histone deacetylase inhibitors |
EP3871669A1 (en) | 2012-02-03 | 2021-09-01 | Italfarmaco SpA | Diethyl-[6-(4-hydroxycarbamoyl-phenyl-carbamoyloxy-methyl)-naphthalen-2-yl-methyl]-ammonium chloride for use in the treatment of muscular dystrophy |
ITUB20155193A1 (it) | 2015-11-03 | 2017-05-03 | Italfarmaco Spa | Sospensioni orali di Givinostat fisicamente e chimicamente stabili |
WO2018054960A1 (en) | 2016-09-21 | 2018-03-29 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for predicting and treating resistance to chemotherapy in npm-alk(+) alcl |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2800498A (en) * | 1954-09-12 | 1957-07-23 | Lab Dausse | Carbamates of dialkylaminoalkyl p-aminobenzoates |
SE379755B (ja) * | 1970-09-09 | 1975-10-20 | Ciba Geigy Ag | |
US3804888A (en) * | 1971-05-17 | 1974-04-16 | Morton Norwich Products Inc | 2-p-nitrobenzamidoacetohydroxamic acid |
US3728380A (en) * | 1971-05-17 | 1973-04-17 | Morton Norwich Products Inc | P-chlorobenzamidoacetohydroxamic acid |
GB1577345A (en) * | 1976-06-10 | 1980-10-22 | Eisai Co Ltd | Hydroxamic acid derivatives of use in the treatment of urolithiasis and pyelonephrosis |
IL60888A (en) * | 1978-06-16 | 1984-07-31 | Yeda Res & Dev | Substrates and process for the quantitative assay of enzymes |
JPS5668650A (en) * | 1979-11-07 | 1981-06-09 | Otsuka Pharmaceut Co Ltd | Benzoic acid amide derivative |
GB8506870D0 (en) * | 1985-03-16 | 1985-04-17 | Wellcome Found | Aryl derivatives |
US4792560A (en) * | 1985-04-03 | 1988-12-20 | Rorer Pharmaceutical Corporation | Quinoline hydroxamates and their use as modulators of arachidonic acid metabolic pathways |
US4711900A (en) * | 1986-07-23 | 1987-12-08 | E. R. Squibb & Sons, Inc. | Certain arylalkyl or pyridylalkyl hydroxamates useful for treating allergies and asthma |
US4681894A (en) * | 1986-09-26 | 1987-07-21 | Ortho Pharmaceutical Corporation | Hydroxamic acids and esters |
US5280015A (en) * | 1990-09-05 | 1994-01-18 | The United States Of America As Represented By The Department Of Health And Human Services | 2-substituted adenosines and 2-substituted adenosine 5'-carboxamides |
-
1996
- 1996-05-14 IT IT96MI000968A patent/IT1283637B1/it active IP Right Grant
-
1997
- 1997-05-12 EP EP97923053A patent/EP0901465B1/en not_active Expired - Lifetime
- 1997-05-12 US US09/180,606 patent/US6034096A/en not_active Expired - Lifetime
- 1997-05-12 CN CN97195410A patent/CN1105100C/zh not_active Expired - Lifetime
- 1997-05-12 ES ES97923053T patent/ES2151267T3/es not_active Expired - Lifetime
- 1997-05-12 CZ CZ19983667A patent/CZ293233B6/cs not_active IP Right Cessation
- 1997-05-12 HU HU9902818D patent/HU225650B1/hu unknown
- 1997-05-12 SK SK1579-98A patent/SK282174B6/sk not_active IP Right Cessation
- 1997-05-12 DE DE69703207T patent/DE69703207T2/de not_active Expired - Lifetime
- 1997-05-12 AU AU28964/97A patent/AU713300B2/en not_active Expired
- 1997-05-12 PT PT97923053T patent/PT901465E/pt unknown
- 1997-05-12 DK DK97923053T patent/DK0901465T3/da active
- 1997-05-12 CA CA002254066A patent/CA2254066C/en not_active Expired - Lifetime
- 1997-05-12 HU HU9902818A patent/HUP9902818A3/hu unknown
- 1997-05-12 WO PCT/EP1997/002407 patent/WO1997043251A1/en active IP Right Grant
- 1997-05-12 JP JP54050597A patent/JP4108127B2/ja not_active Expired - Lifetime
- 1997-05-12 PL PL97329873A patent/PL187527B1/pl unknown
- 1997-05-12 RU RU98122430/04A patent/RU2177473C2/ru active
- 1997-05-12 BR BRPI9709234-7B8A patent/BR9709234B8/pt not_active IP Right Cessation
-
2000
- 2000-12-19 GR GR20000402810T patent/GR3035128T3/el unknown
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002536364A (ja) * | 1999-02-04 | 2002-10-29 | エス ケー コーポレイション | テトラヒドロイソキノリンアルカノール誘導体及びそれを含む薬学的組成物 |
JP2004509941A (ja) * | 2000-09-29 | 2004-04-02 | プロリフィクス リミテッド | Hdacインヒビターとしてのアミド結合を含むカルバミン酸化合物 |
JPWO2003070691A1 (ja) * | 2002-02-21 | 2005-06-09 | 財団法人大阪産業振興機構 | N−ヒドロキシカルボキサミド誘導体 |
JP2006515609A (ja) * | 2003-01-10 | 2006-06-01 | イタルファルマコ ソシエタ ペル アチオニ | 抗炎症性作用を有するヒドロキサム酸誘導体 |
JP4769248B2 (ja) * | 2004-07-05 | 2011-09-07 | イタルファルマコ ソシエタ ペル アチオニ | 抗炎症活性を有するα−アミノ酸誘導体 |
JP2012505872A (ja) * | 2008-10-15 | 2012-03-08 | ジェネリクス・(ユーケー)・リミテッド | ボリノスタットの調製方法 |
US8883851B2 (en) | 2008-10-15 | 2014-11-11 | Generics [Uk] Limited | Process for the preparation of vorinostat |
US9162974B2 (en) | 2008-10-15 | 2015-10-20 | Generics (Uk) Limited | Process for the preparation of vorinostat |
US8754129B2 (en) | 2008-11-26 | 2014-06-17 | Generics [Uk] Limited | Crystalline vorinostat form VI |
JP2022527146A (ja) * | 2019-03-06 | 2022-05-31 | イタルファルマコ ソシエタ ペル アチオニ | 高純度を有する{6-[(ジエチルアミノ)メチル]ナフタレン-2-イル}メチル[4-(ヒドロキシカルバモイル)フェニル]カルバメートを製造するための方法 |
JP7507777B2 (ja) | 2019-03-06 | 2024-06-28 | イタルファルマコ ソシエタ ペル アチオニ | 高純度を有する{6-[(ジエチルアミノ)メチル]ナフタレン-2-イル}メチル[4-(ヒドロキシカルバモイル)フェニル]カルバメートを製造するための方法 |
Also Published As
Publication number | Publication date |
---|---|
DE69703207T2 (de) | 2001-02-01 |
HU225650B1 (en) | 2007-05-29 |
CN1221403A (zh) | 1999-06-30 |
ES2151267T3 (es) | 2000-12-16 |
CN1105100C (zh) | 2003-04-09 |
PL329873A1 (en) | 1999-04-12 |
WO1997043251A1 (en) | 1997-11-20 |
SK282174B6 (sk) | 2001-11-06 |
HUP9902818A3 (en) | 2001-10-29 |
DK0901465T3 (da) | 2000-12-18 |
AU2896497A (en) | 1997-12-05 |
CZ293233B6 (cs) | 2004-03-17 |
BR9709234B8 (pt) | 2014-04-15 |
EP0901465B1 (en) | 2000-09-27 |
PL187527B1 (pl) | 2004-07-30 |
JP4108127B2 (ja) | 2008-06-25 |
CA2254066C (en) | 2007-09-11 |
CA2254066A1 (en) | 1997-11-20 |
ITMI960968A1 (it) | 1997-11-14 |
CZ366798A3 (cs) | 1999-06-16 |
BR9709234A (pt) | 1999-08-10 |
RU2177473C2 (ru) | 2001-12-27 |
DE69703207D1 (de) | 2000-11-02 |
BR9709234B1 (pt) | 2009-01-13 |
SK157998A3 (en) | 1999-04-13 |
EP0901465A1 (en) | 1999-03-17 |
AU713300B2 (en) | 1999-11-25 |
PT901465E (pt) | 2001-01-31 |
US6034096A (en) | 2000-03-07 |
GR3035128T3 (en) | 2001-04-30 |
IT1283637B1 (it) | 1998-04-23 |
ITMI960968A0 (ja) | 1996-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2000510472A (ja) | 抗炎症および免疫抑制活性を有する化合物 | |
RU2140907C1 (ru) | Бициклические соединения и фармацевтическая композиция | |
AU691941B2 (en) | New HIV protease inhibitors | |
CA2430355A1 (en) | Tetralone derivatives as antitumor agents | |
JPH0688957B2 (ja) | 抗高脂質血性および抗アテローム動脈硬化性化合物および組成物 | |
EP0372466A2 (en) | 2-Amino-4 or 5-methoxycyclohexyl amides useful as analgesics | |
JP4293988B2 (ja) | 塩基性非ペプチド性ブラジキニンアンタゴニスト及びそれから得られた医薬組成物 | |
EP2141147A1 (en) | Ornithine derivative | |
JP2000503010A (ja) | アミジノプロテアーゼ阻害剤 | |
JP2003520270A (ja) | ミクロソームトリグリセリド輸送タンパク質およびアポリポタンパク質分泌の阻害剤として有用なカルボキサミド | |
HU211517A9 (en) | 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them | |
US5206428A (en) | Tetrahydronaphthalene derivatives and preparation thereof | |
JPH04234839A (ja) | 尿素誘導体又はその塩 | |
CA1157478A (en) | Carboximidamide derivatives | |
JP2002518470A (ja) | ヒトcd23の産生およびその放出の阻害剤としてのヒドロキサム酸誘導体 | |
KR100479198B1 (ko) | 항염증및면역억제활성화합물 | |
JPH02152950A (ja) | ジヒドロカフェイン酸誘導体およびそれを有効成分として含有する治療剤 | |
MXPA98009473A (en) | Compounds with anti-inflammatory and immunosupreso activities | |
CN108456179B (zh) | 具有神经保护作用的化合物tva-x及其制备方法和应用 | |
CN1984885A (zh) | 双环芳香族亚硫酰基衍生物 | |
JP2003519211A (ja) | Cd23形成の阻害剤として使用のための2−,3−アミノ−4−(n−ヒドロキシアミノ)−スクシニルアミノ−アセトアミド |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20031218 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20071211 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20071211 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080201 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20080318 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080402 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110411 Year of fee payment: 3 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120411 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120411 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130411 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130411 Year of fee payment: 5 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140411 Year of fee payment: 6 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |